Lotter Mark 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Apr 21, 2011
Insider Transaction Report
Form 4
Lotter Mark
DirectorCEO, China Operations
Transactions
- Award
Non-Qualified Stock Option
2011-04-20+100,000→ 300,000 totalExercise: $4.63Exp: 2021-04-20→ Common Stock (100,000 underlying) - Award
Non-Qualified Stock Option
2011-04-20+200,000→ 300,000 totalExercise: $4.63Exp: 2021-04-20→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]Provided Reporting Person remains employed by the Issuer, 50% of the option would vest on April 18, 2012, and approximately 2.0833% of the option would vest each month thereafter.
- [F3]Provided Reporting Person remains employed by the Issuer, the option would vest based upon the achievement of certain financial performance metrics of the Issuer as determined upon the completion of the Issuer's audit for the fiscal year ending December 31, 2012 or alternatively upon the completion of the Issuer's audit for the fiscal year ending December 31, 2013, with the option vesting upon completion of the audit confirming attainment of each of two specified goals and with 50,000 shares issuable under the option vesting for each of the two specified goals achieved. The option will not vest and will terminate with respect to each 50,000 share portion if the associated target is not achieved upon the completion of the Issuer's audit for the fiscal year ending December 31, 2013.